Clinical trial

Clinical Application of Multi-modal Sentinel Lymph Node Staining Method in Breast Cancer Patients After Neoadjuvant Chemotherapy

NCT06212440

StatusCOMPLETED

Study typeINTERVENTIONAL

Start date2021-05-04

PhaseNA

Study timeline

Study start (actual)2021-05-04Date precision: day

Registry last updated2025-03-13

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Sentinel Lymph Node Biopsyunresolved

Neoadjuvant Therapyunresolved

Breast Neoplasmunresolved

Interventions

Radioactive Isotope (RI) MappingDIAGNOSTIC_TEST

Indocyanine Green Fluorescence (ICG-F) MappingDIAGNOSTIC_TEST

Vital Dye MappingDIAGNOSTIC_TEST

Sponsors & collaborators

National Cancer Center, Korealead sponsor

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT06212440 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.